News
LABD
20.82
-8.44%
-1.92
Navigate Biotech's Crosscurrents With Direxion's LABU And LABD ETFs
Benzinga · 1d ago
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF
Seeking Alpha · 2d ago
Weekly Report: what happened at LABD last week (1208-1212)?
Weekly Report · 5d ago
Weekly Report: what happened at LABD last week (1201-1205)?
Weekly Report · 12/08 09:01
SEC warns Direxion, ProShares, and Tidal, stalling new leveraged ETF launches
Seeking Alpha · 12/03 06:00
SDOW Benefits, Risks And Leveraged ETF Watchlist
Seeking Alpha · 12/01 13:00
Weekly Report: what happened at LABD last week (1124-1128)?
Weekly Report · 12/01 09:01
Weekly Report: what happened at LABD last week (1117-1121)?
Weekly Report · 11/24 09:01
Weekly Report: what happened at LABD last week (1110-1114)?
Weekly Report · 11/17 09:01
Weekly Report: what happened at LABD last week (1103-1107)?
Weekly Report · 11/10 09:01
Weekly Report: what happened at LABD last week (1027-1031)?
Weekly Report · 11/03 09:01
Leveraged ETF Watchlist And SPUU's Ongoing Drift
Seeking Alpha · 11/02 12:09
Weekly Report: what happened at LABD last week (1020-1024)?
Weekly Report · 10/27 09:01
Weekly Report: what happened at LABD last week (1013-1017)?
Weekly Report · 10/20 09:01
Weekly Report: what happened at LABD last week (1006-1010)?
Weekly Report · 10/13 09:01
Weekly Report: what happened at LABD last week (0929-1003)?
Weekly Report · 10/06 09:01
Leveraged ETF Watchlist And Focus On SSO's Decay
Seeking Alpha · 10/01 14:05
Weekly Report: what happened at LABD last week (0922-0926)?
Weekly Report · 09/29 09:01
Weekly Report: what happened at LABD last week (0915-0919)?
Weekly Report · 09/22 09:01
Weekly Report: what happened at LABD last week (0908-0912)?
Weekly Report · 09/15 11:15
More
Webull provides a variety of real-time LABD stock news. You can receive the latest news about Direxion Daily S&P Biotech Bear 3X ETF through multiple platforms. This information may help you make smarter investment decisions.